Rationale and design of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE).

导出 OA

翻译打印收藏纠错

作者： Steven K,Grinspoon ^[1] ; Kathleen V,Fitch ^[2] ; Edgar Turner,Overton ^[3] ; Carl J,Fichtenbaum ^[4] ; Markella V,Zanni ^[2] ; Judith A,Aberg ^[5] ; Carlos,Malvestutto ^[6] ; Michael T,Lu ^[7] ; Judith S,Currier ^[8] ; Craig A,Sponseller ^[9] ; Myron,Waclawiw ^[10] ; Beverly,Alston-Smith ^[11] ; Katharine,Cooper-Arnold ^[10] ; Karin L,Klingman ^[11] ; Patrice,Desvigne-Nickens ^[10] ; Udo,Hoffmann ^[7] ; Heather J,Ribaudo ^[12] ; Pamela S,Douglas ^[13] ; REPRIEVE Investigators

作者单位： MGH Program in Nutritional Metabolism and Harvard Medical School, Boston, MA. Electronic address: sgrinspoon@mgh.harvard.edu. ^[1] MGH Program in Nutritional Metabolism and Harvard Medical School, Boston, MA. ^[2] Division of Infectious Diseases, University of Alabama at Birmingham School of Medicine, Birmingham, AL. ^[3] Division of Infectious Diseases, University of Cincinnati College of Medicine, Cincinnati, OH. ^[4] Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY. ^[5] Division of Infectious Diseases, Ohio State University Wexner Medical Center, Columbus, OH. ^[6] Cardiac MR PET CT Program and Department of Radiology, Massachusetts General Hospital, Boston, MA. ^[7] David Geffen School of Medicine at University of California Los Angeles, Division of Infectious Diseases, Los Angeles, CA. ^[8] Kowa Pharmaceuticals America, Inc., Montgomery, AL. ^[9] National Institutes of Health/National Heart, Lung, and Blood Institute, Bethesda, MD. ^[10] DAIDS, NIAID, NIH, Bethesda, MD. ^[11] Center for Biostatistics in AIDS Research, Department of Biostatistics, Harvard TH Chan School of Public Health, Boston, MA. ^[12] Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC. ^[13]

主题词成年人(Adult);老年人(Aged);女(雌)性(Female);人类(Humans);男(雄)性(Male);中年人(Middle Aged);抗HIV药(Anti-HIV Agents);心血管疾病(Cardiovascular Diseases);胆固醇, LDL(Cholesterol, LDL);双盲法(Double-Blind Method);HIV感染(HIV Infections);羟甲基戊二酰基CoA还原酶抑制剂(Hydroxymethylglutaryl-CoA Reductase Inhibitors);一级预防(Primary Prevention);前瞻性研究(Prospective Studies);喹啉类(Quinolines);危险因素(Risk Factors);临床试验, Ⅲ期(主题)(Clinical Trials, Phase III as Topic);多中心研究(主题)(Multicenter Studies as Topic);随机对照试验(主题)(Randomized Controlled Trials as Topic)

DOI 10.1016/j.ahj.2018.12.016

PMID 30928825

发布时间 2024-03-15

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览8

American heart journal

2019年212卷

23-35页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Rationale and design of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE).

American heart journal

相似文献

American heart journal

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Rationale and design of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE).

American heart journal

相似文献

American heart journal

相关期刊

检索历史清除